financial post
Boehringer’s HERNEXEOS® approved in China as first oral targeted therapy for previously treated patients with HER2-mutant advanced NSCLC
Financial Post • 20 DAYS AGO
A base deep in the Swedish forest is part of Europe’s hope to compete in the space race
Financial Post • 20 DAYS AGO
1.2M immigrants are gone from the US labor force under Trump, preliminary data shows
Financial Post • 20 DAYS AGO